Antioxidant dietary approach in treatment of fatty liver: New insights and updates

Non-alcoholic fatty liver disease (NAFLD) is a common clinicopathological condition, encompassing a range of conditions caused by lipid deposition within liver cells. To date, no approved drugs are available for the treatment of NAFLD, despite the fact that it represents a serious and growing clinic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG Jg. 23; H. 23; S. 4146
Hauptverfasser:	Ferramosca, Alessandra, Di Giacomo, Mariangela, Zara, Vincenzo
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 21.06.2017
Schlagworte:	Animals Anthocyanins - pharmacology Antioxidants - pharmacology Carotenoids - pharmacology Catechin - analogs & derivatives Catechin - pharmacology Coumestrol - pharmacology Curcumin - pharmacology Energy Metabolism Fatty Liver - diet therapy Fatty Liver - metabolism Glucosinolates - pharmacology Humans Imidoesters - pharmacology Isothiocyanates - pharmacology Lipogenesis Mitochondria - metabolism Mitochondria - pathology Non-alcoholic Fatty Liver Disease - diet therapy Non-alcoholic Fatty Liver Disease - metabolism Nutritional Sciences Oxidative Stress Polyphenols - pharmacology Quercetin - pharmacology Resveratrol Stilbenes - pharmacology Xanthophylls - pharmacology Oxidative stress Mitochondria Fatty liver Hepatic steatosis Lipogenesis
ISSN:	2219-2840, 2219-2840
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!